No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
No Data
H.C. Wainwright Maintains SATELLOS BIOSCIENCE INC(MSCLF.US) With Buy Rating, Raises Target Price to $0.86
Satellos Appoints Stephanie Brown to Board of Directors
Satellos Bioscience Inc. GAAP EPS of -C$0.08 Misses by $0.04
Satellos Reports Q3 2024 Financial Results and Provides Clinical Update
Satellos to Participate in November 2024 Investor Conferences
Capricor Reports Positive Long-term Data for DMD Drug Deramiocel